As shown in Figure 1, BC patients with high expression of ANXA1/2/3/5/6 had a shorter OS time in comparison to those with low expression of ANXA1/2/3/5/6, while BC patients with high expressed ANXA11 had a longer OS time. Here, ANXA1 is linked to breast cancer.